Metabolic disorders affecting the liver and heart: Therapeutic efficacy of miRNA-based therapies?

Liver and heart disease are major causes of death worldwide. It is known that metabolic alteration causing type 2 diabetes (T2D) and Nonalcoholic fatty liver (NAFLD) coupled with a derangement in lipid homeostasis, may exacerbate hepatic and cardiovascular diseases. Some pharmacological treatments c...

• Autor Principal: La Sala, Lucia (author)
• Outros autores: Carlini, Valentina (author), Conte, Caterina (author), Macas-Granizo, Maria Belen (author), Afzalpour, Elham (author), Martin-Delgado, Jimmy (author), D’Anzeo, Marco (author), F.E. Pedretti, Roberto (author), Naselli, Angelo (author), Pontiroli, Antonio E. (author), Cappato, Riccardo (author)
• Formato: article
• Publicado: 2024
• Subjects: ASOs; Heart diseases; Liver dysfunction; MiRNAs; ModRNAs; RNA therapy; Druggable targets
• Acceso en liña: https://doi.org/10.1016/j.phrs.2024.107083; http://repositorio.ikiam.edu.ec/jspui/handle/RD_IKIAM/773